MARKET

EPIX

EPIX

ESSA Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.910
-0.090
-1.80%
Closed 16:00 02/27 EST
OPEN
4.800
PREV CLOSE
5.00
HIGH
5.21
LOW
4.320
VOLUME
16.36K
TURNOVER
--
52 WEEK HIGH
6.14
52 WEEK LOW
1.410
MARKET CAP
101.94M
P/E (TTM)
-3.6341
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of EPIX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average EPIX stock price target is 8.00 with a high estimate of 8.00 and a low estimate of 8.00.

EPS

EPIX News

More
  • ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders
  • PR Newswire · 6h ago
  • EPIX: IND Filing for EPI-7386 in 1Q20…
  • Zacks Small Cap Research · 02/18 11:10
  • ESSA Pharma Q1 EPS $(0.22) Up From $(0.42) YoY
  • Benzinga · 02/13 22:50
  • ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2019
  • CNW Group · 02/13 22:48

Industry

Biotechnology & Medical Research
-2.24%
Pharmaceuticals & Medical Research
-2.52%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About EPIX

ESSA Pharma, Inc. is a Canada-based pharmaceutical company. The Company is focused on developing therapies for the treatment of castration-resistant prostate cancer (CRPC). It is developing EPI-7386 for the treatment of metastatic CRPC (mCRPC). It is also developing EPI-7386 combination therapy for mCRPC. Its pipeline also includes antinen for triple negative androgen receptor (AR+) breast cancer. Its proprietary aniten compounds bind to the N-terminal domain of the androgen receptor (AR), inhibiting ARdriven transcription and the AR signaling pathway in a manner which bypasses the drug resistance mechanisms associated with current anti-androgens.
More

Webull offers kinds of ESSA Pharma Inc stock information, including NASDAQ:EPIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EPIX stock news, and many more online research tools to help you make informed decisions.